alkaline salt mixture
Dietary Supplementblood and tissue alkalinisation
Other names: Basica
NCT Number: NCT04229069
Metabolism is controlled by macro- and micronutrients. Protein-rich diets should lead to latent acidosis at tissue level with further negative implications. Food supplements with alkaline salts are available and popular pretending to prevent these changes.
Within a randomized double-blind placebo-controlled trial, the investigators tested the hypotheses 1) that a 4-week protein-rich diet induces a latent tissue acidosis and 2) an alkaline supplement can compensate this. Acid-base balance and important metabolic parameters were determined before and after 4 weeks of supplementation by peripheral blood samples, indirect calorimetry and muscle microdialysis before and after a protein-rich test meal.
Looking for future studies?
Notify Me60 year–70 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
blood and tissue alkalinisation
Other names: Basica
no blood and tissue alkalinisation
Time frame: before and after 4-weeks of supplementation at baseline (after a 12 hours overnight fast) and 60, 120, and 180 minutes after a protein-enriched test meal
surrogate measure for muscle tissue pH
Charite University, Berlin, Germany
Other
Randomized, Double-blind, Placebo-controlled Intervention Study on Effects of Basica® on Acid-base Balance, Metabolism and Quality of Life in Elderly Healthy Volunteers.
Acronym: BASICA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05861700
Acid-Base Balance Disorder, Acid-Base Imbalance
Warsaw, Poland
View Trial DetailsNCT06726473
Acid-Base Balance Disorder, Acute Respiratory Distress Syndrome (ARDS)
Guangzhou, Guangdong, China
View Trial DetailsNCT02476253
Acid-Base Imbalance, Acidosis
Montpellier, France
View Trial DetailsNCT04010630
Acid-Base Imbalance, Acidosis
Montpellier, France
View Trial Details